Abstract
Photodynamic inactivation (PDI) and NO-releasing chitosan nanoparticles (CSNPs) were associated to treat cutaneous leishmaniasis in mice to verify synergism between therapies. Parasite burden, lesion size and hyperalgesia were analyzed. CSNPs were not able to improve PDI.
© 2018 The Author(s)
PDF ArticleMore Like This
Fernanda V. Cabral, Cheng Lian, Saydulla Persheyev, Ifor D.W. Samuel, and Martha S. Ribeiro
Tu4A.39 Latin America Optics and Photonics Conference (LAOP) 2022
Stuart K. Bisland, Jeffery Siewerdsen, Albert Yee, Brian C. Wilson, and Shane Burch
TuA3 European Conference on Biomedical Optics (ECBO) 2005
Jun Qian, Arash Gharibi, Xin Li, and S. He
SuN4 Asia Optical Fiber Communication and Optoelectronic Exposition and Conference (ACP) 2008